Biotech

All Articles

Amgen reports very first phase 3 gain for $400M dermatitis medication

.Amgen has actually discussed (PDF) the very first period 3 information on its own $400 thousand ecz...

Biogen, UCB file stage 3 lupus win after stopping working earlier trial

.Biogen as well as UCB's gamble on improving right into stage 3 astride a failed research study trie...

Aptadir wishes brand-new RNA preventions may reverse tricky cancers

.Italian biotech Aptadir Rehabs has actually released along with the commitment that its own pipelin...

Wave surfs DMD results to regulatory authorities' doors, delivering stock up

.Surge Lifestyle Sciences has satisfied its own goal in a Duchenne muscle dystrophy (DMD) research, ...

Sanofi tweezes brand new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma fold, takin...

Achilles drops tissue treatment plan, supports for unemployments after missing 'industrial feasibility' objectives

.Achilles Therapeutics has actually shreded its own tactic. The English biotech is actually quiting ...

Aligos declares period 2 MASH succeed, slashing liver excess fat around 46%

.Aligos Therapeutics is heralding a midstage gain in metabolic-dysfunction linked steatohepatitis (M...

Basilea credit ratings $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job establishing new antifungals has actually obtained a substantial boost ...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Having presently scooped up the united state legal rights to Capricor Therapeutics' late-stage Duch...

FDA fragments adcomm for Applied's unusual health condition medicine

.After pushing the choice meeting for Applied Rehabs' metabolic ailment drug govorestat, the FDA has...